Gram Research analysis shows that specific genetic variations in the CYP2R1 gene, which controls vitamin D processing, significantly increase type 2 diabetes risk in Jordanian populations. People carrying the AG version of the rs10741657 variation had over 6 times higher odds of developing diabetes compared to those without it, according to a 2026 case-control study of 395 participants. These genetic markers could help identify high-risk individuals early, though lifestyle factors like diet and exercise remain crucial for prevention.
Scientists in Jordan discovered that certain genetic variations in the CYP2R1 gene, which controls how your body processes vitamin D, may increase the risk of developing type 2 diabetes. Researchers compared 200 people with diabetes to 195 healthy people and found that specific genetic patterns were much more common in those with diabetes. These genetic markers could help doctors identify who is at higher risk for diabetes in the future. The findings suggest that vitamin D processing in the body plays an important role in diabetes development, opening new possibilities for prevention and treatment strategies.
Key Statistics
A 2026 case-control study of 395 Jordanian participants found that people carrying the AG genotype of the CYP2R1 rs10741657 variation had 3.69 times higher risk of type 2 diabetes compared to those without this genetic variation.
According to research reviewed by Gram, the CYP2R1 rs1074165 A allele increased type 2 diabetes risk by 4.68 times in a study of 200 diabetes patients and 195 healthy controls from Jordan.
A 2026 genetic study found that people with the AG version of CYP2R1 rs10741657 had over 6 times higher odds of type 2 diabetes when using advanced statistical analysis, compared to those without this genetic variation.
Research showed that two other vitamin D-related genes, CYP24A1 and CYP27B1, did not show significant associations with type 2 diabetes risk in the Jordanian population, suggesting CYP2R1 is particularly important in diabetes development.
The Quick Take
- What they studied: Whether specific genetic variations that affect how your body uses vitamin D are linked to type 2 diabetes risk
- Who participated: 395 people total: 200 with type 2 diabetes and 195 healthy people without diabetes, all from Jordan
- Key finding: Two specific genetic variations in the CYP2R1 gene were significantly more common in people with diabetes, with one variation increasing diabetes risk by nearly 4 times
- What it means for you: If you carry these genetic variations, you may have a higher natural risk for type 2 diabetes, but genetics is only part of the story. Diet, exercise, and lifestyle choices still matter greatly. Genetic testing could help identify at-risk individuals for earlier monitoring and prevention.
The Research Details
This was a case-control study, which means researchers compared two groups of people: those who already had type 2 diabetes and those who did not. They looked at the DNA of 200 people with diabetes and 195 healthy controls, all living in Jordan. The researchers examined specific spots in genes related to vitamin D processing, looking for tiny variations called SNPs (single nucleotide polymorphisms). Think of SNPs like typos in the instruction manual for making proteins. Using a genetic testing method called T-ARMS-PCR, they identified which people carried which genetic variations and compared the frequencies between the two groups.
Understanding the genetic basis of diabetes is important because it helps explain why some people are naturally more susceptible to the disease. If certain genetic variations increase diabetes risk, doctors could use genetic testing to identify high-risk individuals early. This allows for preventive measures before diabetes develops. Additionally, understanding the genetic pathway through vitamin D could lead to new treatments or better ways to manage the disease.
This study has several strengths: it used a clear comparison between people with and without diabetes, had a reasonable sample size of 395 participants, and used established genetic testing methods. However, the study was limited to people from Jordan, so results may not apply equally to other populations with different genetic backgrounds. The study is relatively recent (2026) and provides new information, but findings should be confirmed by larger studies in different populations before being widely applied clinically.
What the Results Show
Two genetic variations in the CYP2R1 gene showed strong associations with type 2 diabetes. The first variation, called rs10741657, was significantly more common in people with diabetes. People carrying the AG version of this genetic variation had 3.69 times higher risk of diabetes compared to those without it. The G allele (one copy of the genetic variation) increased risk by 2.59 times. The second variation, rs1074165, showed even stronger associations. People with the GA version had 4.27 times higher diabetes risk, and carrying the A allele increased risk by 4.68 times. When researchers used more advanced statistical analysis, they found that people carrying the AG version of rs10741657 had over 6 times higher odds of having diabetes compared to others.
Two other genetic variations examined in the study, one in the CYP24A1 gene and one in the CYP27B1 gene, did not show significant associations with diabetes risk. This suggests that not all genes involved in vitamin D processing equally affect diabetes development. The CYP2R1 gene appears to be particularly important in the vitamin D pathway related to diabetes risk.
Previous research has suggested that vitamin D deficiency is linked to type 2 diabetes, but this study goes deeper by identifying specific genetic variations that affect how efficiently the body processes vitamin D. The findings align with earlier research showing vitamin D’s role in insulin sensitivity and blood sugar control. However, this is one of the first studies to specifically examine these genetic variations in a Jordanian population, suggesting that genetic risk factors may vary between different ethnic groups.
This study was conducted only in Jordan, so the results may not apply equally to people from other ethnic backgrounds or geographic regions. The sample size of 395 people is moderate; larger studies would provide more reliable results. The study is observational, meaning it shows associations but cannot prove that these genetic variations directly cause diabetes. Other factors like diet, exercise, and family history also play important roles. Additionally, the study did not measure actual vitamin D levels in participants, so the connection between genetic variations and vitamin D function is inferred rather than directly measured.
The Bottom Line
If you are of Jordanian or similar Middle Eastern descent and have a family history of diabetes, genetic testing for these CYP2R1 variations could help assess your personal risk level. This information should be combined with lifestyle modifications: maintain a healthy weight, exercise regularly, eat a balanced diet, and ensure adequate vitamin D intake through sunlight exposure or supplements. Consult with a healthcare provider about whether genetic testing is appropriate for you. These findings are promising but still emerging, so they should complement rather than replace standard diabetes screening and prevention strategies.
People with a family history of type 2 diabetes, particularly those of Jordanian or Middle Eastern descent, should pay attention to these findings. Healthcare providers in these populations may find this information useful for identifying high-risk individuals. People already diagnosed with type 2 diabetes may benefit from understanding their genetic predisposition. However, people without family history or those from very different ethnic backgrounds may have different genetic risk profiles.
Genetic risk is lifelong, but it does not mean you will definitely develop diabetes. Lifestyle changes can reduce risk significantly even if you carry these genetic variations. Benefits from improved diet and exercise typically appear within weeks to months in terms of blood sugar control. Long-term prevention of diabetes through lifestyle modification may take years to fully demonstrate, but the earlier you start, the better your chances of avoiding the disease.
Frequently Asked Questions
Can genetic testing predict if I will get type 2 diabetes?
Genetic testing can identify increased risk, but it cannot predict with certainty whether you will develop diabetes. These CYP2R1 variations increase risk by 4 to 6 times, but many people with these genes never develop diabetes. Lifestyle choices like diet, exercise, and weight management remain equally or more important than genetics.
What does the CYP2R1 gene do in my body?
The CYP2R1 gene produces a protein that helps convert vitamin D into an active form your body can use. This active vitamin D helps control blood sugar levels and insulin sensitivity. Genetic variations in this gene may reduce how efficiently your body processes vitamin D, potentially increasing diabetes risk.
Should I take vitamin D supplements if I have these genetic variations?
Consult your healthcare provider about appropriate vitamin D supplementation based on your blood levels and individual needs. While vitamin D is important for blood sugar control, more is not always better. A doctor can recommend the right dose for your situation, typically 1000 to 2000 IU daily for most adults.
Are these genetic findings relevant if I am not from Jordan?
These findings are most directly applicable to people of Jordanian or Middle Eastern descent, as the study was conducted in that population. However, similar genetic variations likely affect people from other backgrounds differently. Genetic risk factors can vary significantly between ethnic groups, so consult your doctor about your specific risk profile.
Can I prevent diabetes if I carry these genetic variations?
Yes, lifestyle modifications can significantly reduce diabetes risk even with genetic predisposition. Maintaining a healthy weight, exercising regularly, eating a balanced diet low in refined sugars, and ensuring adequate vitamin D intake can help prevent or delay diabetes onset despite genetic risk factors.
Want to Apply This Research?
- If you have genetic testing showing these CYP2R1 variations, track your vitamin D levels quarterly through blood tests and log your vitamin D intake from food and supplements daily in the app. Monitor fasting blood sugar levels monthly to catch any early changes.
- Users with these genetic variations should set a daily goal of 30 minutes of moderate exercise and track vitamin D intake targets (1000-2000 IU daily depending on individual needs). Log weekly weight measurements and maintain a food diary focusing on whole grains, lean proteins, and vegetables while limiting refined sugars.
- Establish a baseline with genetic testing and vitamin D blood levels, then retest vitamin D annually and blood sugar markers every 6 months. Use the app to track trends over time and share results with your healthcare provider to adjust prevention strategies as needed.
This article discusses genetic research findings and should not be interpreted as medical advice or a substitute for professional medical consultation. Genetic testing and interpretation should only be performed by qualified healthcare providers. If you have concerns about your diabetes risk or family history of diabetes, consult with your doctor or a genetic counselor. These findings are based on a study in a Jordanian population and may not apply equally to all ethnic groups. Genetic predisposition is only one factor in diabetes development; lifestyle, diet, and other health factors play equally important roles.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.